LAB SCHEDULE 13G/A: SEC filing

MAK Capital Fund LP, MAK Capital One LLC, and Michael A. Kaufman

Filed with the SEC on · accession 0001019056-26-000164

LAB filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. MAK Capital Fund LP, MAK Capital One LLC, and Michael A. The stock moved -12.2% by the first close after the filing.

Summary of the filing

MAK Capital Fund LP, MAK Capital One LLC, and Michael A. Kaufman filed an amended Schedule 13G reporting beneficial ownership of 24,979,153 shares, or 6.3%, of Standard BioTools Inc. common stock as of September 30, 2026. The filing is a passive investment disclosure under Rule 13d-1(c).

Key details

Shares of common stock beneficially owned$25.0M
Total shares of common stock outstanding$394.8M
Issuer of the securitiesStandard BioTools Inc.
Reporting person / beneficial ownerMAK Capital Fund LP
Reporting person / beneficial ownerMAK Capital One LLC
Managing member of mak capital one llc and mak gp llcMichael A. Kaufman

How LAB stock reacted

Close before

$0.71

Nov 13, 2026

First close after

-12.21%

$0.62

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for LAB, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for LAB?

Click here

Frequently asked questions

What did LAB file with the SEC on Nov 16, 2026?

LAB filed a SCHEDULE 13G/A (SEC filing). MAK Capital Fund LP, MAK Capital One LLC, and Michael A. Kaufman filed an amended Schedule 13G reporting beneficial ownership of 24,979,153 shares, or 6.3%, of Standard BioTools Inc. common stock as of September 30, 2026. The filing is a passive investment disclosure under Rule 13d-1(c).

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did LAB stock react to this filing?

LAB closed at $0.71 before the filing and $0.62 on Nov 16, 2026 (-12.21%).

Other LAB SEC filings

Get alerts when LAB files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days